Keith Katkin

Keith Katkin

Chairman chez ELEDON PHARMACEUTICALS, INC.

Fortune : 1 M $ au 31/03/2024

52 ans
Health Technology
Consumer Services
Commercial Services

Profil

Keith A.
Katkin
is currently serving as the Chairman at Eledon Pharmaceuticals, Inc., an Independent Director at Syndax Pharmaceuticals, Inc., an Independent Director at Emergent BioSolutions, Inc., and a Director at both the Brain Injury Association of America, Inc. and Transposon Therapeutics, Inc. Previously, he held the positions of President, Chief Executive Officer & Director at Avanir Pharmaceuticals, Inc. from 2007 to 2016, President, Chief Executive Officer & Director at Urovant Sciences, Inc. from 2017 to 2020, Chief Executive Officer & Director at Urovant Sciences Ltd.
from 2018 to 2020, Chairman at Otic Pharma Ltd.
from 2015 to 2017, Independent Director at Rigel Pharmaceuticals, Inc. from 2015 to 2022, Independent Class III Director at Carbylan Therapeutics, Inc. from 2014 to 2016, and Vice President-Commercial Development at Peninsula Pharmaceuticals, Inc. from 2004 to 2005.
Mr. Katkin received his undergraduate degree from Indiana University in 1993 and his MBA from Anderson School of Management in 2000.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
07/02/2024 49 000 ( 0,06% ) 1 M $ 31/03/2024
25/05/2023 42 442 ( 0,08% ) 107 378 $ 31/03/2024
01/05/2023 677 ( 0,00% ) 1 395 $ 31/03/2024
31/01/2023 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Keith Katkin

SociétésPosteDébut
SYNDAX PHARMACEUTICALS, INC. Director/Board Member 29/03/2017
ELEDON PHARMACEUTICALS, INC. Chairman 01/05/2017
EMERGENT BIOSOLUTIONS INC. Director/Board Member 01/04/2022
Brain Injury Association of America, Inc. Director/Board Member -
Director/Board Member -
Tous les postes actifs de Keith Katkin

Anciens postes connus de Keith Katkin

SociétésPosteFin
RIGEL PHARMACEUTICALS, INC. Director/Board Member 01/05/2022
UROVANT SCIENCES LTD. Chief Executive Officer 23/03/2020
Chief Executive Officer 01/01/2020
Director/Board Member 01/04/2017
░░░░ ░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Keith Katkin

Formation de Keith Katkin

Indiana University Undergraduate Degree
Anderson School of Management Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Keith Katkin

Relations

100 +

Relations au 1er degré

16

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
RIGEL PHARMACEUTICALS, INC.

Health Technology

SYNDAX PHARMACEUTICALS, INC.

Health Technology

EMERGENT BIOSOLUTIONS INC.

Health Technology

ELEDON PHARMACEUTICALS, INC.

Health Technology

Entreprise privées10

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Brain Injury Association of America, Inc.

Finance

Health Technology

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Keith Katkin